Authors
Jin, Q., Wu, Y., Deng, H., Zeng, W., Brown, J. S., Wang, J., Zhang, J.-R.
Abstract
The capsules of invasive bacteria shield underlying antigens, limit immune clearance and hinder vaccine noncapsular antigen discovery. To address this, we developed Liver-based Vaccine Antigen Capture (L-VAC), a functional platform integrating antibody-mediated screening with in vivo visualization of hepatic bacterial clearance in mice. Applying L-VAC to Streptococcus pneumoniae identified multiple capsule-permeable proteins that induce rapid hepatic clearance of blood-borne bacteria. Immunization with these proteins, especially in a multivalent formulation, conferred broad cross-serotype protection. Spatial analyses revealed that only the proteins localized at or near the capsular surface are targetable for vaccine-induced pathogen capture in the liver sinusoids. These findings establish L-VAC as a sensitive and reliable approach for identifying protective protein antigens capable of overcoming capsule barriers, offering a promising strategy to develop broadly protective vaccines against multidrug-resistant encapsulated pathogens.
Preprint server:
bioRxiv
The authors list and abstract were imported from bioRxiv on 14 Nov 2026.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 69
- Comments 0